We observed a decrease in phosphorylated AMPK at threonine 172 in breast cancer cells with TRPV2 knockdown (Fig. 6A-C), while treatment with cannabidiol resulted in increased phosphorylation of AMPK at threonine 172 (Fig. 6D-E). This evidence concerns the gene TRPV2 and breast carcinoma.